Trials / Unknown
UnknownNCT04146168
Lake Washington Vascular VenaSeal™ Post-Market Evaluation
Clinical and Patient-Centered Outcomes Three Years After Venaseal Treatment: Lake Washington Vascular VenaSeal Post Market Evaluation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 124 (estimated)
- Sponsor
- Lake Washington Vascular · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
New-WAVES Study seeks to expand understanding/results from prior study (NCT02585726). Assessing both clinical outcomes and patient satisfaction after treatment with Venaseal/Cyanoacrylate Adhesive Closure System
Detailed description
New WAVES is an investigator initiated protocol that will assess clinical outcomes and patient satisfaction after treatment with VenaSeal(TM)/ Cyanoacrylate Adhesive Closure System 3 years post-treatment. All patients treated from a multi-provider practice, whom meet protocol inclusion criteria, will be invited to consider participation in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Ultrasound | Closure of previously treated veins (with Venaseal) will be assessed via ultrasound. |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2020-01-01
- Completion
- 2020-03-01
- First posted
- 2019-10-31
- Last updated
- 2019-10-31
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04146168. Inclusion in this directory is not an endorsement.